ResMed (RMD) Reports In-Line Q1 EPS
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $223.61 -0.61%
Revenue Growth %: +6.9%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +6.9%
Financial Fact:
Total other income, net: -1.22M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.51, in-line with the analyst estimate of $1.51. Revenue for the quarter came in at $950.3 million versus the consensus estimate of $947.96 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Ledyard Financial Group adds two directors, three retire
- Endava CFO placed on leave amid accounting probe
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
